What You Missed:
Our 6 Years of Foundations with the R&D Lab Operations, Asset & Facilities Community
We embarked on the lab operations and facility transformation journey with the likes of Regeneron, Janssen, Merck 6 years ago in Boston. Fast forward to 2023, we are seeing similar trends happening in Europe. The demand for productivity, capital efficiency and innovation with the non-negotiable emphasis of speed-to-clinic adds huge pressure to biotechs and biopharma on operational excellence. The ability to anticipate asset and lab space requirement, create an R&D lab to drive collaboration will ultimately empower scientists to advance their experiments, supporting pipeline progression.
With the unique geographic challenges in Europe, achieving scale of economy and accessing talents don’t make it easy for Lab Operations, Lab Facility & R&D leads. The Lab Asset & Facility Management in Pharma Summit Europe aims to help you solve these urgent problems through 17+ case studies, panel discussions and roundtables, equipping you with first-hand lessons learned but also an opportunity to gain practical tips from fellow colleagues. Whether you are a young biotech, pharma giant, Dx lab or CRO, the 3-day summit content was curated with you in mind – allowing you to walk away and begin making a change to increase agility and flexibility.
Your 5 Unmissable Case Studies
Roche leverages asset utilisation data to drive behavioural change and demonstrate the potential impact on future assets utilisation and space purchasing decisions
Synthace explores their lab sustainability project while identifying the main challenges, defining necessary KPI’s and outlining their innovative approaches via lessons learnt
Synnovis joins forces with the NHS to create the largest pathology lab in Europe and all the challenges that come along with it from capital, design and sustainability perspectives
GSK explores the best facility management practices, looking into challenges associated with cross country distribution, centralisation/consolidation of spend and evaluating outsourcing to allow you to make informed decisions
Novartis shares their approaches to effective asset lifecycle management for R&D equipment, including categorisation, surplus management and asset depreciation allowing you to make the most of your assets in 2023